| Issue Date | Title | Author(s) |
| 2016-06 | Using a Delphi process to determine optimal care for patients with pancreatic cancer. | Burmeister, EA; Jordan, SJ; O'Connell, DL; Beesley, VL; Goldstein, D; Gooden, HM; Janda, M; Merrett, ND; Wyld, D; Neale, RE; Pancreatic Cancer Clinical Working Group, |
| 2018 | Development of Indicators to Assess Quality of Care for Prostate Cancer | Nag, N; Millar, J; Davis, ID; Costello, S; Duthie, JB; Mark, S; Delprado, W; Smith, D; Pryor, D; Galvin, D; Sullivan, F; Murphy, Á; Roder, D; Elsaleh, H; Currow, D; White, C; Skala, M; Moretti, KL; Walker, T; De Ieso, P; Brooks, A; Heathcote, P; Frydenberg, M; Thavaseelan, J; Evans, SM |
| 2017-11 | What is symptom meaning? A framework analysis of communication in palliative care consultations. | Estacio, CF; Butow, PN; Lovell, MR; Dong, ST; Clayton, JM |
| 2017-10 | Delivering an empowerment intervention to a remote Indigenous child safety workforce: Its economic cost from an agency perspective. | Kinchin, I; Doran, CM; McCalman, J; Jacups, S; Tsey, K; Lines, K; Smith, K; Searles, A |
| 2018-07-02 | "It doesn't exist…": negotiating palliative care from a culturally and linguistically diverse patient and caregiver perspective. | Kirby, E; Lwin, Z; Kenny, K; Broom, A; Birman, H; Good, P |
| 2018-01 | A retrospective audit on usage of Diatrizoate Meglumine (Gastrografin®) for intestinal obstruction or constipation in patients with advanced neoplasms. | Heng, S; Hardy, J; Good, P |
| 2018-08 | The meaning and experience of bereavement support: A qualitative interview study of bereaved family caregivers. | Kirby, E; Kenny, K; Broom, A; MacArtney, J; Good, P |
| 2017-04 | Psychiatry trainees' views and educational needs regarding the care of patients with a life-limiting illness. | Forster, BC; Proskurin, H; Kelly, B; Lovell, MR; Ilchef, R; Clayton, JM |
| 2017-10 | Experiences of interpreters in supporting the transition from oncology to palliative care: A qualitative study. | Kirby, E; Broom, A; Good, P; Bowden, V; Lwin, Z |
| 2017-09 | Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer? | George, R; Haywood, A; Good, P; Hennig, S; Khan, S; Norris, R; Hardy, J |
